Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Candor Rx vs Mint Med

Candor Rx
Graded #60

Lower grade

vs+9.900000000000006
Mint Med
Graded #22

Higher grade

The verdict

Mint Med takes it — 84.7/100 to 74.8/100.

Mint Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low both-molecule pricing ($117/$159) and verified — but only 36 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCandor Rx +6
96
90
Dose & formulationMint Med +8
72
80
Clinical oversightMint Med +9
76
85
Labs & monitoringMint Med +31
52
83
FulfillmentMint Med +11
71
82
Contract termsMint Med +25
61
86
Candor Rx · left barMint Med · right bar

The numbers

MetricCandor RxMint Med
WeighScore74.8/10084.7/100
GradeCB
Scorecard rank#60#22
Semaglutide$99/mo (all doses, compounded)$117/mo
Tirzepatide$149/mo (all doses, compounded)$159/mo
CoverageCoverage not published36 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Candor Rx

Graded #60 · C

Strengths

  • Flat, dose-independent pricing marketed as '$95/month, any dose, forever' — no upcharge as your dose increases
  • Low starting prices: compounded semaglutide as low as $99/mo and tirzepatide as low as $149/mo
  • Medication ships in about 48 hours and you can cancel anytime
  • Simple, transparent GLP-1 focus with pricing shown up front before signup

Where it loses points

  • Prescribing medical group and compounding pharmacy are not named on the site
  • States of operation are not published; confirm eligibility during intake
  • No LegitScript certification is displayed
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Mint Med

Graded #22 · B

Strengths

  • $117 sema / $159 tirz
  • LegitScript-verified
  • Both molecules

Where it loses points

  • Only 36 states
  • Injection-only
  • Monitoring detail sparse

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard